NRx Pharmaceuticals, Inc. (NRXP) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of NRx Pharmaceuticals, Inc. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NRXP
NRx Pharmaceuticals, Inc.
$2.97HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.03HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — NRXP vs PYXS
growth of $100 · dividends reinvested · last 5yNRXP -96.6% (-49.2%/yr)PYXS -83.0% (-29.9%/yr)PYXS compounded faster over this window
Log scale — wide-divergence pair
NRXP PYXS
NRXP vs PYXS: by the numbers
- •PYXS is the larger company ($128M vs $128M market cap).
- •Both run net losses; NRXP's is the smaller (-691.81% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | NRXP | PYXS |
|---|---|---|
| P/S ratio | 37.82 | 11.64 |
| P/B ratio | N/A | 11.23 |
Profitability
| Metric | NRXP | PYXS |
|---|---|---|
| Gross margin | 58.78% | 82.77% |
| Operating margin | -1324.41% | -609.18% |
| Net margin | -691.81% | -803.83% |
| ROE | N/A | -775.59% |
| ROIC | N/A | -314.66% |
Growth (annualized)
| Metric | NRXP | PYXS |
|---|---|---|
| Total return CAGR (5Y) | -49.61% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.